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Abstract 
In this paper, our aim is to explore, develop, design and implement a prototype system for multi-agent 
cancer diagnosis in selected organs (Lung, Kidney and Liver) that finds the possibility of illness, its 
severity, and its potential complications including a statistical belief, based on the patient's symptoms and 
laboratory examinations. Moreover, the system gives prescriptions for treatment and makes useful 
indications and suggestions. The final medical diagnosis is based on decisions made by all the JADE 
agents. The system’s overall utility is an increasingly pervasive way of conceptualizing automatic 
diagnosis and prognosis of cancer. Finally we apply fuzzy model to classify stages of lung, kidney cancers 
and calculate survival rate of patients. 
 
© 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of C3IT
 
Keywords:  Cancer Diagnosis; Fuzzy Model; Multi Agent System; JADE 
 
1. Introduction 
Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. In 2010, 
an estimated 58,240 new cases of kidney (renal) cancer are expected to be diagnosed. Kidney cancer 
includes renal cell carcinoma (92%), renal pelvis carcinoma (7%), and Wilms tumor (1%), a childhood 
cancer that usually develops before age five. kidney cancer incidence rates are increasing since 1975 by 
1.8% per year in men and 2.4% per year in women. Five-year survival is lower for renal pelvis (51%) than 
for renal cell (70%) carcinoma. Since 1980, the incidence of liver cancer has been steadily increasing due 
to increasing attacks of hepatitis B, Hepatitis C Viruses and high-risk behaviors such as drug and alcohol 
usage. In 2010, an estimated 24,120 new cases of liver cancer are expected to occur of which more than 
80% of these cases are hepatocellular carcinoma (HCC), originating from hepatocytes, the predominant 
type of cell in the liver. Five-year survival is 26% among patients in whom cancer is detected at an early 
stage, compared to only 2% when spreaded to distant organs. Lung cancer is currently responsible for 
29% of cancer deaths also responsible for more deaths than breast cancer, colon cancer, and prostate 
cancer combined. Even though more women are diagnosed with breast cancer, and more men with 
prostate cancer, lung cancer remains the leading cause of cancer deaths for both men and women[1]. 
1.1 Why Agents for Cancer Diagnosis  
       We utilize multi-agent systems to deal with many different kinds of problems in cancer diagnosis, 
including patient scheduling and management, medical information access and management, and decision 
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support. Coordination and confrontation among agents are often necessary for cancer diagnoses when a 
group of specialists   are involved in a mutual diagnosis and treatment plan for a patient[2]. Our Novel 
architecture utilizes multi agents where distributed knowledge-based systems are considered as 
cooperative agents in cancer diagnoses. 
2. Related Works     
In this section we review all the computer aided diagnostic models for lung, kidney and liver cancers 
Surveys summarize tumor classification techniques are based on pattern recognition and clustering 
methods applicable in the field of artificial neural networks for principal component transformations [3].  
Segmentation of lung  reviews different methods that can be used for efficient visualization as well as 
automatically extracting the organ regions from abdominal CT (Computerized tomography) data which 
can be further used in various medical diagnosis applications like CBMIR (Content-based medical image 
retrieval) [4] .The main purposes of the modified c-means radial basis functions are to diagnose the cancer 
diseases by using fuzzy rules with relatively small number of linguistic labels, reduce the similarity of the 
membership functions and preserve the meaning of the linguistic labels [5]. Important aspects that need to 
be considered on building a successful pre-surgical planning system includes the common imaging 
modalities used in liver diagnosis, several 3D visualization techniques, some basic ideas on surface 
rendering, and the important liver components used in pre-surgical planning [6]. Our proposed model 
takes decision based on coordination mechanism that is need for integration in final diagnosis. Also every 
agent encapsulates an abdicative analysis mechanism that, given a set of practical symptoms, allows 
particular agent to devise their own diagnosis. 
3. Architectural Specification 
Each running instance of the JADE runtime environment is called a Container as it can contain several 
agents. The set of active containers is called a Platform. A single special Main container must always be 
active in a platform and all other containers register with it as soon as they start. The AMS (Agent 
Management System) provides the naming service and represents the authority in the platform. The DF
(Directory Facilitator) that provides a Yellow Pages service by means of which an agent can find other 
agents providing the services he requires in order to achieve his goals. The Analyser/Patient/Examiner 
represents that any number of agents can run in a platform. The participating agents are distributed all 
over the platform, so coordination is extremely important in cancer diagnoses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                            
 
 
 
 
    Fig 1.System Architecture
In our proposed system, Database/Administrator/Controller Agent node is activated as main container in 
their own module with which other agents/nodes get registered with. The system is applicable peer to peer 
model so all the main and other containers must be inter connected through a high performance network 
cable. 
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4. Implementation  
In  an open-source platform, the cancer diagnosis system is implemented using the Jade agent 
development environment, Java and JavaDB derby database, supported in  Windows and Linux platforms, 
and forms a distributed environment with  four different types of computing nodes with at least one active 
Database agent, as depicted in Figure 1.  
4.1. Preprocessing Module It applies data analysis and discovers an algorithm to fabricate a picky 
inventory of patterns over the data.It also involves the evaluation of patterns and detection of which leads 
to knowledge representation.  
4.1.1 Data Selection. As a first step the symptoms needs to be carefully selected for all the three types of 
cancer based on expert knowledge 
4.1.2 Preprocessing. The target data often requires preprocessing ie., it involves in selecting relevant 
symptoms and filtering out the repeated symptoms.   
4.1.3 Transformation. It is a process that selects an optimal subset of symptoms based on specialist 
domain knowledge.   
4.1.4 Data Mining. It consists of applying data analysis algorithms that, under acceptable efficiency 
limitations, produce a particular enumeration of patterns over the data. Here, the sequential pattern mining 
is applied to find frequent subsets from the available subsets of symptoms.  
4.1.5 Interpretation and Evaluation. The results of the sequential pattern data mining algorithm are 
analyzed and interpreted. This step reveals that nine symptoms subsets analysis sare enough to diagnosis 
cancer of specific organ.   
4.2 Fuzzification and Calculation of Triangular Membership Function   
    While diagnosing stages of cancer (not applicable for liver cancer) it is hardly essential to determine the     
survival rate of patient for that particular stage of cancer. For this reason, we use fuzzy rule based model 
to diagnosis the overall five year survival rate in every stage.   
4.2.1Calculation of Membership function for Renal (Kidney) Cancer  
    Based on the size of tumor, age, disease spread and redundancy 
(http://www.cancer.gov/cancertopics/types/kidney), we calculate membership            function for Renal 
Cell Cancer as follows:     
 
Table 1. Membership Function for Renal Cell cancer                                                                    
  Range (cm)          Stage                  Functional Model 
0.1- 2.5  
 2.6-5.0 
 5.1 - 7.0 
 
Renal:  I  
 
       
      
 
                  0 
                          Į                 ȕ               Ȗ 
 
 
                 ȁ(u:Į,ȕ,Ȗ)        =0                                 u<Į 
= (u-Į)/ (ȕ-Į)               Į<=u<=ȕ 
= 1                                ȕ+1 
= (Ȗ - u)/( Ȗ -ȕ)             ȕ+2<=u<=Ȗ 
=0                         u>Ȗ 
 
7.1-7.5 
 7.6- 10  
  >=10 
 
Renal: II 
<=7 
 7.1-10.0  
  >=10 
Renal:  III 
 
 1
1
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Table 2. Rule Generation; TNM: Tumor, Node, Metastasis; DS: Disease spread beyond Kidneys  
Stage I  
 
Stage II  
 
Stage III  
 
If (0.1 <= T <= 2.5)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= high  
}  
If (2.6 <= T <= 5.0)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= medium  
}  
If (5.1 <= T <= 7.0)  
{  
                        Survival =low  
}  
If (7.1 <= T <= 7.5)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= high  
}  
If (7.6 <= T <= 10.0)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= medium 
}  
If (T >= 10.0)  
{  
                        Survival =low  
}  
If (0.1 <= T <= 7.0)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= high  
}  
If (7.1 <= T <= 10.0)  
{  
     If (DS =true)  
                        Survival =low  
    Else If (DS=false)  
                         Survival= medium 
}  
If (T >= 10.0)  
{  
                        Survival =low  
}  
4.2.2 Calculation of Membership function for Non Small Cell (Lung) Cancer  
      Based on the size of tumor (http://www.cancer.gov/cancertopics/types/lung), we calculate 
membership function for Non Small Cell Cancer as follows:  
Table 3.  Membership Function for Non Small Cell cancer  
Input Field Range (cm) Stage
Tumor      size <= 0.9 
1.0 - 1.9  
2.0 - 3.0 
NSCLC:  IA 
3.0 - 5.0 
5.1 - 7.0 
>= 7.1 
NSCLC:  IB 
<= 0.9 
1.0 - 1.9  
2.0 – 3.0 
NSCLC:  IIA 
3.0 – 5.0 
5.1 – 7.0 
>= 7.1 
NSCLC:  IIB 
0.1-3.0 (T1N2MO) 
3.1-5.0 (T2N2MO) 
>=5.1 (T3N1MO)  
>   >=5.1 (T3N2MO) 
NSCLC: IIIA 
>=7.1(AnyTN3MO) 
5.1-7.0(T3AnyNM0) 
NSCLC:  IIIB 
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Table 4. Rule Generation; TNM: Tumor, Node, Metastasis; R: Redundancy of the Tumor; A: Age of the Patient; PS: 
Primary Symptoms  
Stage IA, II A  
 
 If (0.1 <= T <= 0.9)  
{  
     If         (R=true && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A>=40 && PS =false)  
                        Survival =low  
    Else If (R= false && A>=40 && PS=false)  
                         Survival= high  
     Else If(R=true && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A<=40 && PS =false)  
                        Survival =low  
     Else If (R= false && A<=40 && PS=false)  
                         Survival= high  
}  
If (1.0 <= T <= 1.9)  
{  
     If         (R=true && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A>=40 && PS =false)  
                        Survival =low  
    Else If (R= false && A>=40 && PS=false)  
                         Survival= medium  
     Else If(R=true && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A<=40 && PS =false)  
                        Survival =low  
     Else If (R= false && A<=40 && PS=false)  
                         Survival= medium  
}  
If (2.0 <= T <= 3.0)  
{  
                        Survival =low  
}  
Stage III A  
If (0.1 <= T <= 3.0)  
{  
     If (R=true && A>=40 && PS =true)  
                        Survival =low  
    Else If ( R= false && A<=40 &&        PS=false ) 
                         Survival= high  
}  
If (3.1 <= T <= 5.0)  
{  If (R=true && A>=40 && PS =true)  
                        Survival =low } 
   Else If ( R= false && A<=40 
&&ps=false{Survival=medium} 
If(T>=5.1) {survival=low} 
Stage IB, IIB  
 
 If (3.0 <= T <=   5.0)  
{  
          If         (R=true && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A>=40 && PS =false)  
                        Survival =low  
    Else If (R= false && A>=40 && PS=false)  
                         Survival= high  
     Else If(R=true && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A<=40 && PS =false)  
                        Survival =low  
     Else If (R= false && A<=40 && PS=false)  
                         Survival= high  
}  
If (5.1 <= T <= 7.0)  
{  
          If         (R=true && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A>=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A>=40 && PS =false)  
                        Survival =low  
    Else If (R= false && A>=40 && PS=false)  
                         Survival= medium  
     Else If(R=true && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=false && A<=40 && PS =true)  
                        Survival =low  
     Else If (R=true && A<=40 && PS =false)  
                        Survival =low  
     Else If (R= false && A<=40 && PS=false)  
                         Survival= high  
}  
If (>= 7.1)  
{  
                        Survival =low  
}  
 
Stage III B  
If (5.1 <= T <= 7.0)  
{  
     If (R=true && A>=40 && PS =true)  
                        Survival =low  
    Else If (R= false && A<=40 && PS=false)  
                         Survival= high  
}  
If ( T >= 7.1)  
{  
                        Survival =low  
}  
 
4.3 Cancer Diagnosis Framework  
 
Authorizer   :  Does Authorization/Authentication of patients  
Symptom Checker  :  Predicts liver cancer by checking against basic symptoms  
Coordinator  :  Confirms appointment to scan/tests, and updates results in database  
Report sheet 
Generator  
:  Concludes disease stage, treatment plan specific to a patient  
Case History  
Analyzer  
:  Creates technical knowledge tree of all treatment related data corresponding to a 
patient  
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Graphical Analyzer  :  Manipulates graphical view of improvement in patient’s health in response to 
treatment  
Security and Trust  :  Provides security to message exchange between experts  
4.3.1 Symptom Checker Agent.  Includes a classical decision tree which usually makes a decision based on main 
symptoms of the patient particularly to a cancer.   
     
Fig 2. (a)Symptom checker for Lung Cancer  (b)Symptom Checker for Kidney cancer  
 
4.3.2 User/Patient Agent. Involves in registering patient personal details with database for authentication 
processes and usually describes his/her symptoms and medical history. According to different results (Yes/No) 
if essential appointment is made. Finally involves in displaying stage of cancer, doctor’s prescription and 
diagnosis to his/her patient            
4.3.3 Analyser /Doctor/ Diagnoiser Agent. It acts in three major roles which are as follows:  
  
  
Fig 3. (a)Prescription Report  (b) Diagnosis report 
 
(a) Report Generator Displays the Laboratory and scan reports regarding which helps in concluding the stage of 
cancer, survival rate in selected organs using fuzzy component model. The individual medical reports and 
diagnoses are stored as valid data in database for use when required by patients.  
(b)  History Analyser. Creates knowledge tree representation of all the medical reports of individual patients and 
provide option for patients to view their individual report detail which is highly useful for both patient and 
diagnoiser to decide upon further decisions on treatment          
(c)  Performance Analyser. Displays Graphical view ie., Time Series Chart to manipulate and monitor 
improvement in patient’s  health with response to the treatment.     
4.3.4 Technical/Coordinator/ Examiner Agent.  Firstly, verifies social decision-making concepts like 
authorization and appointment to suit the special needs of multi agent cancer diagnoses. Secondly, performs 
practical examinations and stores tumor related details of selected organs in database.     
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  Fig 4. Technical Report   
 
4.3.5 Database/Administrator/Controller Agent. All agents usually communicate with database through this 
agent for storing, viewing or modifying patient personal and medical data.   
 5. Experimental Results  
Accuracy: Accuracy is the degree of correctness to calculate the performance of the system. The higher the 
accuracy the better the performance of the system.  
Accuracy=TP+TN/TP+TN+FP+FN  
Sensitivity: It is a measure of how a system properly identifies condition and concludes solution. (ie) 
identifying    specific cancer type, its stage and the survival rate.   
Sensitivity = TP/TP+FN  
Specificity: It is a measure of how a system properly identifies the wrong solutions. (ie)  probability that the 
system indicates negative results  for the patient.  
Specificity = TN/TN+FP  
CASES Affected Not-Affected  
 
Table 5.  Evaluation  
 
 
Lung Cancer        30  15  
Kidney Cancer     30  15  
Liver Cancer        30  15  
  
 
   Lung  Kidney Liver 
 TP   25   23   21  
 TN   5   7   9  
 FP   12   11   9  
 FN   3   4   6  
 Accuracy   0.67  0.66   0.66 
 Sensitivity  0.676 0.851  0.777 
 Specificity  0.294 0.388  0.5  
  
  
6. Performance Evaluation  
 
   In our proposed model the performance is analyzed with the number of users against average response time 
and throughput.  
6.1 Response Time  
The performance of agents is analyzed against client server model, using various parameters such as increasing 
number of users, average response time and throughput. Since we do not use a request -response or a queuing 
system response time is less. As the number of users increases, the average response time for Agent based 
system is better when compared to systems without agents. Analysis of number of users against average 
response time is depicted in figure 5.  
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Average Response Time(secs)
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No. of  
users 
       Average Response Time in  
                Seconds  
  Without 
Agents
With Agents 
1  24.018 11.531 
2  32.246 11.841 
3  32.532 11.521 
4  33.101 13.091 
5  33.239 13.281 
6  33.581 13.432 
7  34.011 14.056 
8  34.321 14.097 
9  35.055 15.058 
10  35.285 15.323 
Fig 5. Average Response Time  Table 6. Comparitive chart of Average Response 
Time  
6.2 Throughput  
Throughput represents the amount of data transferred between the nodes. As the number of user increases, the 
task is carried out in each node so the throughput is high in agent based system (figure 6). The CPU and 
memory utilization are high and the load distribution is uniform in agent based system.  
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No. of 
users  
Average                   
Throughput(bytes/secs) 
 Without 
Agents 
With Agents 
1 650 1000 
2 656 1011 
3 661 1025 
4 687 1051 
5 700 1073 
6 730 1089 
7 747 1129 
8 748 1125 
9 750 1389 
10 754 1620 
  
  
Fig 6.   Average Throughput  Table 7. comparitive chart of  Average Throughput  
 
  7. Conclusion  
 
Our proposed work extends the traditional scope of e-health applications by providing a distributed agent-based 
approach which provides security and privacy to patient data. A final diagnosis compatible with both patient’s 
recovery and accessible medical values can be reached through a joint decision-making procedure in this model. 
The advantage of this approach is that human knowledge is symbolic so encoding is easier, and they can be 
constructed to be computationally complete, which makes it easier for humans to understand the logic. 
Therefore, besides its front-end application of technology to the biomedical field, it acts as a globally distributed 
information and knowledge repository for Cancer diagnosis and prognosis.  
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